Healio13d
Eosinophilic esophagitis incidence, prevalence growing
The incidence and prevalence of eosinophilic esophagitis in the United States are higher than previously reported, indicating increased disease burden, according to a poster presented here. EoE can ...
Medical News Today5d
Nucala vs. Dupixent
Nucala for eosinophilic asthma Dupixent for eosinophilic asthma ... adults and children ages 6 years and older • eosinophilic esophagitis (EoE) in adults and certain children ages 1 year and ...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Medical Dialogues1d
Sanofi Dupixent approved in Japan for COPD
Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...
Gizmodo12d
Man’s Two-Year Hiccups Triggered by Rare Allergy Condition
Unfortunately, these cells also often play a role in causing allergy and asthma symptoms. When everything is ... Subsequent ...
Morningstar3d
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Dupixent has received regulatory approvals in more than 60 countries in one or more indications including certain patients with atopic dermatitis, asthma, CRSwNP, eosinophilic esophagitis (EoE ...
Pharmabiz2d
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...